ARID1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.783600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.699400E-01
Normal-vs-Stage2
2.831600E-01
Normal-vs-Stage3
1.809430E-01
Normal-vs-Stage4
3.753200E-01
Stage1-vs-Stage2
7.531800E-01
Stage1-vs-Stage3
1.342780E-01
Stage1-vs-Stage4
2.329800E-01
Stage2-vs-Stage3
8.762200E-02
Stage2-vs-Stage4
3.761200E-01
Stage3-vs-Stage4
1.183790E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.741200E-01
Normal-vs-AfricanAmerican
1.828850E-01
Normal-vs-Asian
4.451800E-02
Caucasian-vs-AfricanAmerican
2.445200E-01
Caucasian-vs-Asian
7.546200E-01
AfricanAmerican-vs-Asian
3.680400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.772200E-01
Normal-vs-Female
2.819400E-01
Male-vs-Female
8.484200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.155800E-01
Normal-vs-Age(41-60Yrs)
3.142200E-01
Normal-vs-Age(61-80Yrs)
2.680800E-01
Normal-vs-Age(81-100Yrs)
2.403400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.442200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.786000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.310000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.111390E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.637500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.996800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.743800E-01
Normal-vs-Daily Drinker
2.059200E-01
Normal-vs-Weekly Drinker
2.599800E-01
Normal-vs-Occasional Drinker
2.996600E-01
Normal-vs-Social Drinker
3.094200E-01
Non Drinker-vs-Daily Drinker
6.890300E-02
Non Drinker-vs-Weekly Drinker
7.588800E-01
Non Drinker-vs-Occasional Drinker
6.379400E-01
Non Drinker-vs-Social Drinker
5.918200E-01
Daily Drinker-vs-Weekly Drinker
1.645220E-01
Daily Drinker-vs-Occasional Drinker
2.362500E-02
Daily Drinker-vs-Social Drinker
3.340100E-02
Weekly Drinker-vs-Occasional Drinker
4.536600E-01
Weekly Drinker-vs-Social Drinker
4.445200E-01
Occasional Drinker-vs-Social Drinker
9.113000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.139440E-01
Normal-vs-Grade 2
1.643560E-02
Normal-vs-Grade 3
1.718480E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.520400E-01
Grade 1-vs-Grade 3
2.362000E-01
Grade 1-vs-Grade 4
1.139440E-01
Grade 2-vs-Grade 3
2.480400E-01
Grade 2-vs-Grade 4
1.643560E-02
Grade 3-vs-Grade 4
1.718480E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.581800E-01
Normal-vs-NonDiabetic
2.645600E-01
Diabetic-vs-NonDiabetic
7.745000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.576200E-01
Normal-vs-NoPancreatitis
2.655800E-01
Pancreatitis-vs-NoPancreatitis
8.069800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.726200E-01
Normal-vs-N1
2.837200E-01
N0-vs-N1
6.484800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.799600E-01
Normal-vs-TP53-NonMutant
3.268400E-01
TP53-Mutant-vs-TP53-NonMutant
2.371200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
